無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

治験管理システム (CTMS) の世界市場予測 2022年:Webホステッド・オンプレミス・クラウドベース

Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 229587
出版日 ページ情報 英文 266 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.02円で換算しております。
Back to Top
治験管理システム (CTMS) の世界市場予測 2022年:Webホステッド・オンプレミス・クラウドベース Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
出版日: 2018年01月18日 ページ情報: 英文 266 Pages
概要

世界の治験管理システム (CTMS) 市場規模、2017年から2022年にかけて12.6%のCAGR (年間複合成長率) で推移し、2022年までに10億6,560万米ドルに達すると予測されています。バイオ製薬会社とCRO(開発業務受託機関)の間での参加数の増加、進行中の治験数の増加、治験を支援する政府の財源および補助金の増加、先進CTMSソリューションの利用拡大、および顧客ベースのCTMSソリューションの成長といった要因は、CTMS市場の成長を促進しています。

当レポートでは、世界の治験管理システム (CTMS) 市場の現状と見通しについて調査分析し、市場の概要、市場成長への影響因子および市場機会の分析、エンドユーザー・デリバリー形態・コンポーネント・タイプ地域など各種区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • CTMS市場:市場概要
  • 世界のCTMS市場:コンポーネント別
  • 世界のCTMS市場:タイプ別
  • 世界のCTMS市場:エンドユーザー・デリバリー形態別
  • 世界のCTMS市場:国別

第5章 市場ダイナミクス

  • 市場成長促進因子
  • 市場成長抑制因子
  • 市場機会
  • 市場の課題
  • 主な産業動向

第6章 治験管理システム (CTMS) の世界市場:タイプ別

  • 概要
  • エンタープライズCTMS
  • サイトCTMS

第7章 治験管理システム (CTMS) の世界市場:デリバリー形態別

  • 概要
  • Webベース (ホステッド) CTMS
  • ライセンス企業 (オンプレミス) CTMS
  • クラウドベース (SaaS) CTMS

第8章 治験管理システム (CTMS) の世界市場:コンポーネント別

  • 概要
  • ソフトウェア
  • サービス

第9章 治験管理システム (CTMS) の世界市場:エンドユーザー別

  • 概要
  • 医薬品・バイオ医薬品企業
  • CRO (医薬品開発業務受託機関)
  • 医療機器企業
  • その他

第10章 治験管理システム (CTMS) の世界市場:地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 治験管理システム (CTMS) の世界市場:競合情勢

  • 概要
  • CTMS市場シェア分析:主要企業別
  • 競合シナリオおよび動向
    • 新製品の発表および強化
    • 合意、提携、協業
    • 市場の拡大
    • M&A

第12章 企業プロファイル・分析

  • ORACLE
  • MEDIDATA SOLUTIONS
  • PAREXEL
  • BIOCLINICA
  • BIO-OPTRONICS
  • IBM
  • DATATRAK
  • VEEVA SYSTEMS
  • DSG
  • MASTERCONTROL
  • ERT
  • FORTE RESEARCH SYSTEMS
  • MEDNET SOLUTIONS
  • ARISGLOBAL
  • DZS SOFTWARE SOLUTIONS

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: LIST OF PARTNERSHIPS BETWEEN BIOPHARMA COMPANIES AND CROS
  • TABLE 2: GLOBAL CTMS MARKET, BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 3: CTMS MARKET FOR ENTERPRISE CTMS, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 4: CTMS MARKET FOR SITE CTMS, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 5: GLOBAL CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 6: WEB-BASED (ON-DEMAND) CTMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: CLOUD-BASED (SAAS) CTMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: GLOBAL CTMS MARKET, BY COMPONENT, 2017-2022 (USD MILLION)
  • TABLE -1: CTMS MARKET FOR SOFTWARE BY REGION, 2017-2022 (USD MILLION)
  • TABLE 11: CTMS MARKET FOR SERVICES BY REGION, 2017-2022 (USD MILLION)
  • TABLE 12: GLOBAL CTMS MARKET, BY END USER, 2017-2022 (USD MILLION)
  • TABLE 13: CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES BY REGION, 2017-2022 (USD MILLION)
  • TABLE 14: CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES BY TYPE, 2017-2022 (USD MILLION)
  • TABLE 15: CTMS MARKET FOR LARGE PHARMACEUTICAL COMPANIES BY REGION, 2017-2022 (USD MILLION)
  • TABLE 16: CTMS MARKET FOR SMALL-MID SIZED PHARAMCEUTICAL COMPANIES BY REGION, 2017-2022 (USD MILLION)
  • TABLE 17: STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015)
  • TABLE 18: CTMS MARKET FOR CRO BY REGION, 2017-2022 (USD MILLION)
  • TABLE 19: CTMS MARKET FOR MEDICAL DEVICE COMPANIES BY REGION, 2017-2022 (USD MILLION)
  • TABLE 20: CTMS MARKET FOR OTHER END USERS BY REGION, 2017-2022 (USD MILLION)
  • TABLE 21: CTMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: CTMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: US: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 29: US: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 30: US: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 31: US: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: CTMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE : CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE : CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE : CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE : CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE : PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: GERMANY: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 43: GERMANY: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 46: UK: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 47: UK: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: UK: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 49: UK: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: FRANCE: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 51: FRANCE: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: FRANCE : CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 53: FRANCE : CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 54: ROE: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 55: ROE: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: ROE: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: APAC: CTMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: APAC: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 60: APAC: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: APAC: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 62: APAC: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 63: APAC: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: CHINA: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 65: CHINA: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: CHINA: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 67: CHINA: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: JAPAN: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: JAPAN: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 71: JAPAN: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: INDIA: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 73: INDIA: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: INDIA: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 75: INDIA: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 76: ROAPAC: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION))
  • TABLE 77: ROAPAC: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: ROAPAC: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION))
  • TABLE 79: ROAPAC: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 80: ROW: CTMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 81: ROW: CTMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: CTMS MARKET, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: CTMS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: PRODUCT LAUNCHES AND ENHANCEMENTS (2014-2017)
  • TABLE 86: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014-2017)
  • TABLE 87: MARKET EXPANSIONS (2014-2017)
  • TABLE 88: MERGERS AND ACQUISITIONS (2014-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES
  • FIGURE 3: ENTERPRISE CTMS SEGMENT TO HOLD THE LARGEST SHARE OF THE CTMS MARKET IN
  • FIGURE 4: SOFTWARE SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING 2017-
  • FIGURE 5: WEB-BASED CTMS SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 6: CTMS MARKET, BY END USER, 2017 VS.
  • FIGURE 7: NORTH AMERICA TO DOMINATE THE GLOBAL CTMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 8: RISING NUMBER OF CLINICAL TRIALS TO DRIVE THE GROWTH OF THE MARKET (2017-2022)
  • FIGURE 9: SOFTWARE PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL
  • FIGURE 10: ENTERPRISE BASED CTMS PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL
  • FIGURE 11: WEB-BASED CTMS AND PHARMACEUTICAL COMPANIES TO DOMINATE THE CTMS MARKET IN
  • FIGURE 12: CHINA TO BE THE FASTEST-GROWING MARKETS FOR CTMS DURING THE FORECAST PERIOD
  • FIGURE 13: MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
  • FIGURE 14: GLOBAL INCREASE IN THE NUMBER OF CLINICAL TRIALS, 2002-
  • FIGURE 15: GLOBAL CTMS MARKET SHARE, BY TYPE, 2017 VS.
  • FIGURE 16: ENTERPRISE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 17: SITE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 18: GLOBAL CTMS MARKET, BY MODE OF DELIVERY (2017 VS 2022)
  • FIGURE 19: WEB-BASED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN
  • FIGURE 20: WEB-BASED (ON DEMAND) CTMS MARKET SHARE, BY REGION(2017)
  • FIGURE 21: LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET SHARE, BY REGION (2017)
  • FIGURE 22: CLOUD-BASED (SAAS) CTMS MARKET SHARE, BY REGION (2017)
  • FIGURE 23: SOFTWARE SEGMENT TO DOMINATE THE GLOBAL CTMS SOLUTIONS MARKET IN
  • FIGURE 24: SOFTWARE MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 25: SERVICES MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 26: GLOBAL CTMS MARKET, BY END USER,
  • FIGURE 27: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN
  • FIGURE 28: R&D EXPENDITURE OF MAJOR PHARMACEUTICAL COMPANIES, 2015 VS. 2016 (USD MILLION)
  • FIGURE 29: PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 30: LARGE PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 31: MID-SMALL PHARAMCEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 32: CRO SERVICES COVER THE ENTIRE DRUG DEVELOPMENT SPECTRUM
  • FIGURE 33: CRO MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 34: MEDICAL DEVICE COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 35: OTHER END USERS MARKET SHARE, BY GEOGRAPHY (2017)
  • FIGURE 36: CTMS MARKET BY REGION (2017 VS 2022)
  • FIGURE 37: TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (DECEMBER 2017)
  • FIGURE 38: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2015 (USD MILLION)
  • FIGURE 39: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CTMS MARKET, 2014-
  • FIGURE 40: CTMS MARKET SHARE ANALYSIS,
  • FIGURE 41: ORACLE : COMPANY SNAPSHOT
  • FIGURE 42: MEDIDATA SOLUTIONS: COMPANY SNAPSHOT
  • FIGURE 43: PAREXEL : COMPANY SNAPSHOT
  • FIGURE 44: IBM : COMPANY SNAPSHOT
  • FIGURE 45: DATATRAK : COMPANY SNAPSHOT
  • FIGURE 46: VEEVA SYSTEMS : COMPANY SNAPSHOT
目次
Product Code: HIT 1686

"The clinical trial management system (CTMS) market is projected to grow at a CAGR of 12.6% during the forecast period"

The global CTMS market is projected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS market include the increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions. However, the major market restraints are limited awareness among researchers about the advantages of CTMS solutions and budget constraints faced by the emerging countries.

"The cloud-based CTMS segment is expected to grow at the highest rate during the forecast period"

On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.

"Software segment accounted for the largest share of the CTMS market by component"

On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to have the largest share of the market. This is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.

"The APAC market is expected to grow at the highest CAGR during the forecast period"

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world. The APAC market is expected to register the highest growth rate during the forecast period. Increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs are fueling the growth of the APAC CTMS market.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - C-level - 26%, Director level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The major players in the market included are: Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Research Coverage:

This report studies the CTMS market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the CTMS market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY USED
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. BOTTOM-UP APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS
  • 2.5. RESEARCH LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CTMS: MARKET OVERVIEW (2017-2022)
  • 4.2. GLOBAL CTMS MARKET, BY COMPONENT, 2017 VS.
  • 4.3. GLOBAL CTMS MARKET, BY TYPE, 2017 VS.
  • 4.4. GLOBAL CTMS MARKET, BY END-USER AND MODE OF DELIVERY (2017)
  • 4.5. CTMS MARKET BY COUNTRY,

5. MARKET OVERVIEW

  • 5.1. DRIVERS
  • 5.2. RESTRAINTS
  • 5.3. OPPORTUNITIES
  • 5.4. CHALLENGES
  • 5.5. KEY INDUSTRY TRENDS

6. CTMS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. ENTERPRISE CTMS
  • 6.3. SITE CTMS

7. CTMS MARKET, BY DELIVERY MODE

  • 7.1. INTRODUCTION
  • 7.2. WEB-BASED (HOSTED) CTMS
  • 7.3. LICENSED ENTERPRISE (ON PREMISE) CTMS
  • 7.4. CLOUD-BASED (SAAS) CTMS

8. CTMS MARKET, BY COMPONENT

  • 8.1. INTRODUCTION
  • 8.2. SOFTWARES
  • 8.3. SERVICES

9. CTMS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • 9.2.1. LARGE PHARMACEUTICAL COMPANIES
    • 9.2.2. MID-SMALL PHARMACEUTICAL COMPANIES
  • 9.3. CONTRACT RESEARCH ORGANIZATIONS
  • 9.4. MEDICAL DEVICE COMPANIES
  • 9.5. OTHER END USERS

10. CTMS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.1. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE (ROE)
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. CTMS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2016)
  • 11.3. COMPETITIVE SCENARIO AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES AND ENHANCEMENTS (2014-2017)
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014-2017)
    • 11.3.3. MARKET EXPANSIONS (2014-2017)
    • 11.3.4. MERGERS AND ACQUISITIONS (2014-2017)

Top 15 companies analyzed for this studies are - Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US).

12. COMPANY PROFILES (Introduction, Products & Services, Financial Snapshots, Developments, MnM View)*

  • 12.1. ORACLE
  • 12.2. MEDIDATA SOLUTIONS
  • 12.3. PAREXEL
  • 12.4. BIOCLINICA
  • 12.5. BIO-OPTRONICS
  • 12.6. IBM
  • 12.7. DATATRAK
  • 12.8. VEEVA SYSTEMS
  • 12.9. DSG
  • 12.10. MASTERCONTROL
  • 12.11. ERT
  • 12.12. FORTE RESEARCH SYSTEMS
  • 12.13. MEDNET SOLUTIONS
  • 12.14. ARISGLOBAL
  • 12.15. DZS SOFTWARE SOLUTIONS

*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHORS DETAILS
Back to Top